Oxford Knee Replacement
What makes the Oxford Unicompartmental Knee different?The Oxford is the only true mobile meniscal bearing knee system approved for use in the U.S. This design allows the femur (thigh bone) to always be in equal contact with the tibia (shin bone). As the knee flexes, the polyethylene component (plastic spacer) is allowed to move slightly. This allows more uniform contact between the components. Thereby lowering contact pressures and wear. A study has shown an average penetration rate of only 0.03mm per year at a mean follow-up rate of 10.9 years.
How long do they last? * Survivorship of 95% or more at 10 years from several centers.* This rivals the best outcome studies for total knee replacements (Total Knee Replacements are often considered the "gold standard")* Even though the lateral (outside) and patellofemoral (kneecap) portions of the knee are not replaced, this implant appears to impede disease spreading to these areas of the knee. There are 3 components:
The femoral component, the tibial component, and the polyethylene (plastic) tray. How is it implanted?The partial knee replacement is performed through a minimally invasive incision. The incision is generally 3 - 4 inches long (middle of the patella to the tibial tubercle). The arthritic portion of bone is then removed from the tibia (shin bone) with a saw. Next, the arthritic portion of the femur (thigh bone) is removed with a saw and reamer. Finally, the appropriate size polyethylene (plastic tray) is chosen and inserted after the components are cemented in position. X-rays are obtained to evaluate component position. How long am I in the hospital?Because the amount of bone resection and tissue dissection is significantly less, your hospital stay is greatly decreased. Often, patients are able to return home post operative day one. The patient's mobility is greatly increased as well, and rehab stays are generally unnecessary. Can anybody that has knee arthritis have an Oxford Unicompartmental Knee Replacement?No. This implant is indicated for patients that have primarily anteromedial knee arthritis. The patient must not have significant lateral knee arthritis. Interestingly, the amount of patellofemoral (kneecap) arthritis does not seem to matter. Studies from Oxford, England have found that approximately 30% of their patients that have knee arthritis are candidates for this minimally invasive procedure. Other contraindications are:* an infection,* rheumatoid arthritis (inflammatory condition that typically affects the whole joint) or other forms of inflammatory joint disease in the knee,* had a prior knee implant,* failed upper tibial osteotomy or post-traumatic arthritis after tibial plateau fracture,* damaged or missing ligaments in the knee,*disease or damage to the outside (lateral) part of the knee,* osteoporosis and the patient's doctor believes it may affect the knee prosthesis,* disease or metabolic disorder (such as osteomalacia, vascular insufficiency, muscular atrophy, neuromuscular disease, or Charocot's disease) that may impair bone formation and affect the outcome of knee implant surgery,* rapid joint destruction, marked bone loss or bone resorption visible on x-ray* incomplete or deficient soft tissue surrounding the knee,* fixed varus deformity (not passively correctable) of greater than 15 degrees,* flexion deformity greater than 15 degrees, or* is unable to follow a doctor's instruction. How do I know if I am a candidate for this procedure?If your knee pain is primarily located along the inside portion of your knee, you may be a candidate. Remember, there are many conservative measures to control arthritic pain (exercise, weight loss, medication (glucosamine, anti-inflammatories), assistive devices and injections (steroids). When these measures have failed and you are no longer willing to allow your knee to curtail your activity, surgical intervention may be appropriate. Who performs this new procedure?Dr. Thomas is a trained specialist in the Oxford partial knee replacement (Unicompartmental Knee Replacement). This innovative device has been performed in Europe for several decades and now has received FDA approval for use in the U.S. Only surgeons trained in the procedure are allowed to implant the Oxford.